However, there was no obvious correlation between the expression of INSIG1 and clinical outcomes of both GBM (p = 0.25) (Supplementary Figure S2B) and CRC patients (p = 0.16) (Supplementary Figure S2C) who are administrated with BV. Here, INSIG1 is linked to glioblastoma.